カテゴリ： MarketLine, スイス, 企業調査

Actelion Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Actelion Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6911
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Actelion Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Actelion Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Actelion Ltd. (Actelion or ‘the company’) is a biopharmaceutical company focused on the discovery, development and commercialization of low molecular weight drugs to address high unmet medical needs. The company classifies its business into single segment, which primarily focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. It offers variety of drugs for the treatment of cardiovascular disorders, central nervous system disorders, infectious diseases, cancer, and immunological disorders. The company has its operations in North and South America, Europe and Asia Pacific. Actelion is headquartered in Allschwil, Switzerland.

Scope

- Detailed information on Actelion Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Actelion Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Actelion Ltd including a breakdown and examination of key business segments
- Intelligence on Actelion Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Actelion Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Actelion Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Actelion Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Actelion Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Actelion Ltd: Company Overview 9
Actelion Ltd: Overview and Key Facts 9
Actelion Ltd: Overview 9
Actelion Ltd: Key Facts 9
Actelion Ltd: Key Employees 10
Actelion Ltd: Key Employee Biographies 11
Actelion Ltd: Major Products and Services 16
Actelion Ltd: Company History 17
Actelion Ltd: Management Statement 22
Actelion Ltd: Locations and Subsidiaries 24
Actelion Ltd: Key Competitors 25
Actelion Ltd: Company Analysis 26
Actelion Ltd: Business Description 26
Actelion Ltd: SWOT Analysis 28
Actelion Ltd: SWOT Overview 28
Actelion Ltd: Strengths 28
Actelion Ltd: Weaknesses 29
Actelion Ltd: Opportunities 29
Actelion Ltd: Threats 31
Actelion Ltd: Corporate Financial Deals Activity 33
Actelion Ltd: Financial Deals Overview 33
Actelion Ltd: Targets and Partners 35
Actelion Ltd: Top Deals 2014 – 2018YTD* 36
Actelion Ltd: Advisors 37
Actelion Ltd: Top Legal Advisors 37
Actelion Ltd: Top Financial Advisors 37
Actelion Ltd: Partnership 38
Actelion Ltd: Divestments 39
Actelion Ltd: Private Equity and Ownership 40
Actelion Ltd: Recent Developments 41
Actelion Ltd: News and Events Summary 41
Actelion Ltd: Business Expansion 44
Actelion Ltd: Financial Deals 44
Actelion Ltd: Financial Performance 44
Actelion Ltd: Regulatory and Legal Events 45
Actelion Ltd: Research & Development 46
Actelion Ltd: Strategy and Operations 47
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Actelion Ltd: Key Facts
Table 2: Actelion Ltd: Key Employees
Table 3: Actelion Ltd: Company History
Table 4: Actelion Ltd: Locations and Subsidiaries
Table 5: Actelion Ltd: Key Competitors
Table 6: Actelion Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Actelion Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Actelion Ltd: Targets and Partners
Table 9: Actelion Ltd: Top Deals 2014 - 2018YTD*
Table 10: Actelion Ltd: Legal Advisor Ranking by Value (US$m)
Table 11: Actelion Ltd: Financial Advisor Ranking by Value (US$m)
Table 12: Actelion Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Actelion Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: Actelion Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Actelion Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 16: Actelion Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 17: Actelion Ltd: News and Events Summary
Table 18: Actelion Ltd: Business Expansion
Table 19: Actelion Ltd: Financial Deals
Table 20: Actelion Ltd: Financial Performance
Table 21: Actelion Ltd: Regulatory and Legal Events
Table 22: Actelion Ltd: Research & Development
Table 23: Actelion Ltd: Strategy and Operations

List of Figures
Figure 1: Actelion Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Actelion Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Actelion Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 4: Actelion Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 5: Actelion Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Actelion Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Actelion Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Actelion Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • AMTEC Corporation：企業の戦略・SWOT・財務情報
    AMTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary AMTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ReShape Lifesciences Inc (RSLS)：医療機器：M&Aディール及び事業提携情報
    Summary ReShape Lifesciences Inc (ReShape), formerly known as EnteroMedics Inc is a medical device company that develops minimally invasive medical devices to treat obesity and metabolic diseases. The company develops vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic dise …
  • Icagen Inc：企業の戦略的SWOT分析
    Icagen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Immupharma Plc (IMM)：企業の財務・戦略的SWOT分析
    Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Whiting Petroleum Corp (WLL)：企業の財務・戦略的SWOT分析
    Whiting Petroleum Corp (WLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Xspray Pharma AB (XSPRAY)：製薬・医療：M&Aディール及び事業提携情報
    Summary Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The company’s drug candidates include HyNap-Dasa, HyNap-Nilo and HyNap-Sora. Its protein kinase …
  • New Gold Inc
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Aldi Einkauf GmbH & Co oHG：戦略・SWOT・企業財務分析
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CytoBioscience Inc：医療機器：M&Aディール及び事業提携情報
    Summary CytoBioscience Inc (CytoBioscience), formerly Cytocentrics Bioscience GmbH is a biotechnology company that manufactures of medical devices for ion channel research. The company’s products include CytoPatch instrumentations. It provides services such as adult human heart, expression systems, …
  • Compumedics Ltd (CMP)：企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnost …
  • Chemring Ordnance, Inc.：企業の戦略・SWOT・財務情報
    Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Geberit Ag：企業の戦略・SWOT・財務分析
    Geberit Ag - Strategy, SWOT and Corporate Finance Report Summary Geberit Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Korea South-East Power Co Ltd：企業の戦略的SWOT分析
    Korea South-East Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Medical Developments International Ltd (MVP)-製薬・医療分野：企業M&A・提携分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company’s products include penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products which inclu …
  • University College London Hospitals NHS Foundation Trust：企業の戦略的SWOT分析
    University College London Hospitals NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • VWR International LLC-製薬・医療分野：企業M&A・提携分析
    Summary VWR International LLC (VWR) a subsidiary of VWR Corp is a supplier of products, services and solutions to laboratories. The company’s business areas comprise differentiated services, product choice and operational excellence. Its product choice services include supply of beakers, freezers, b …
  • Stanbic Ibtc Holdings Plc
    Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cairn Energy Plc (CNE)：企業の財務・戦略的SWOT分析
    Cairn Energy Plc (CNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Quad/Graphics, Inc.：企業の戦略・SWOT・財務分析
    Quad/Graphics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Quad/Graphics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • T2 Biosystems Inc (TTOO)：製薬・医療：M&Aディール及び事業提携情報
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆